Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut de Radiofarmàcia Aplicada de Barcelona (IRAB) is a specialized center focused on the production and distribution of radiopharmaceuticals, primarily for Positron Emission Tomography (PET) imaging. Located within the Barcelona Science Park (PCB), the facility was established to provide a reliable supply of short-lived isotopes like Fluorine-18 to hospitals and research centers across Catalonia and Spain. IRAB operates under strict Good Manufacturing Practice (GMP) standards and utilizes on-site cyclotrons for the synthesis of diagnostic tracers. The company's portfolio includes essential imaging agents used for the detection and monitoring of cancer, neurological disorders, and cardiac conditions. Following its acquisition by IBA Molecular, the institute was integrated into the global radiopharmaceutical leader Curium, where it continues to function as a key regional production hub.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut de Radiofarmàcia Aplicada de Barcelona.